UBS AM’s ArriVent BioPharma AVBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$643K Buy
+29,555
New +$643K ﹤0.01% 2463
2025
Q1
Sell
-8,165
Closed -$218K 2707
2024
Q4
$218K Buy
+8,165
New +$218K ﹤0.01% 2633